Filing Details
- Accession Number:
- 0001689938-17-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-19 18:54:57
- Reporting Period:
- 2017-12-14
- Accepted Time:
- 2017-12-19 18:54:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1585364 | Perrigo Co Plc | PRGO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1689938 | John Wesolowski | C/O Perrigo Company Plc 515 Eastern Avenue Allegan MI 49010 | Evp, President Rx | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2017-12-14 | 700 | $85.80 | 709 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 200 | Indirect | 401(k) |
Footnotes
- The reporting person's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 700 shares, with the reporting person's sales of: (i) 220 shares of Perrigo common stock at $86.86 per share on November 28, 2017, (ii) 68 shares of Perrigo common stock at $87.64 per share on November 29, 2017, (iii) 100 shares of Perrigo common stock at $87.66 per share on November 29, 2017, and (iv) 312 of 450 shares of Perrigo common stock at $83.09 per share on December 7, 2017. The reporting person has paid Perrigo $544.02, representing the full amount of the profit realized in connection with the short-swing transaction.